Therapy for bipolar ii depression
Treatments studied
Part of Mental health clinical trials.
This trial studies a type of talk therapy (IPSRT) for people with bipolar II disorder who are currently depressed. The aim is to see how well it works and how it affects the brain.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 to 60 years old.
- You must have bipolar II disorder and currently be in a depressive episode.
- You must have been off psychiatric medications for at least 4 weeks.
- You must be of Han Chinese descent and right-handed.
- You must be able to have an MRI scan (no metal implants or claustrophobia).
- You cannot be pregnant or have active suicidal thoughts.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is following and assessing people with major depression or bipolar disorder to better understand the condition and how the brain relates to symptoms. It may help researchers develop more targeted support by comparing brain and health information over time.
This study tests whether a psychedelic drug called psilocybin (the active ingredient in 'magic' mushrooms), combined with therapy, can help relieve depression in people with bipolar II disorder who haven't gotten better with other treatments. You'll receive the drug in a supervised setting and attend follow-up visits to see how it affects your mood.
This trial tests if two doses of psilocybin, given under medical supervision, are safe and acceptable for people with Bipolar II disorder who have mild to moderate depression and certain suicidal thoughts. The goal is to see if it may help improve mood and reduce suicidal thinking.
This trial tests an investigational drug called LB-102 for people with bipolar I disorder who are currently experiencing a major depressive episode without psychosis. It aims to see if the drug is safe and effective for treating depression symptoms.
This trial tests a therapy called behavioral activation to help people with bipolar depression feel better. The therapy focuses on increasing positive activities and routines to improve mood.
This trial tests whether OSU6162 can improve depressive symptoms in adults with bipolar depression who are already taking a stable mood-stabilizing medicine. It also checks safety by closely monitoring mood, heart rhythm, and other health factors during the study.
Hear when a new Bipolar Disorder II trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.